Meeting Abstract RDF
pages:- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- Role of Vitamin D Deficiency in Male Fertility
- Running Ourselves To Death: Does Long Distance Running Increase The Risk Of Venous Thromboembolism?
- Safety and efficacy of bimekizumab through 2 years in patients with moderate to severe plaque psoriasis: Long-term results from BE SURE randomised controlled trial and BE BRIGHT open-label extension
- Safety and Efficacy of Lanreotide Depot Versus Placebo in Neuroendocrine Tumor Patients With a History of Carcinoid Syndrome and Prior Octreotide Therapy
- SAFETY AND EFFICACY OF LANREOTIDE DEPOT VS PLACEBO IN NEUROENDOCRINE TUMOR PATIENTS WITH A HISTORY OF CARCINOID SYNDROME AND PRIOR OCTREOTIDE THERAPY.
- SAFETY AND EFFICACY OF MCC-257 IN DIABETIC PERIPHERAL NEUROPATHY: RESULTS OF A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL AND OPEN-LABEL EXTENSION
- SAFETY AND EFFICACY OF WC2031 VS VIBRAMYCIN FOR THE TREATMENT OF UNCOMPLICATED UROGENITAL CHLAMYDIA TRACHOMATIS INFECTION
- Safety and efficacy results for the segesterone acetate ethinyl estradiol (SA/EE) contraceptive vaginal ring
- Safety and Tolerability of Bazedoxifene/Conjugated Estrogens in Postmenopausal Women: Findings From a 1-Year, Randomized, Placebo- and Active-controlled, Phase 3 Trial
- Safety and Tolerability of Lanreotide Autogel/Depot (LAN) in Patients (pts) with Neuroendocrine Tumours (NETs): Pooled Analysis of Clinical Studies
- Safety and Tolerability of Lanreotide Autogel/Depot in Patients With Neuroendocrine Tumors: Pooled Analysis of Clinical Studies
- SAFETY AND TOLERABILITY OF THE AGILE PATCH, A CONTRACEPTIVE PATCH WITH LOW-DOSE ETHINYL ESTRADIOL (EE) AND LEVONORGESTREL (LNG), VS. COMBINATION ORAL CONTRACEPTIVES (COCS) IN OBESE VS. NON-OBESE WOMEN
- Safety of Oral Ospemifene in Phase 2/3 Placebo-controlled Clinical Trials
- Salvage Surgery for Locoregional Failure after Chemoradiation in Rectal Squamous Cell Carcinoma: A National Cancer Database Analysis
- Salvage Therapy for Recurrent Gastrojejunal Anastomotic Stricture Using a Lumen-Apposing Metal Stent
- SATISFACTION WITH THE SEGESTERONE ACETATE AND ETHINYL ESTRADIOL CONTRACEPTIVE VAGINAL SYSTEM AMONG PREVIOUS ORAL CONTRACEPTIVE OR CONTRACEPTIVE VAGINAL RING USERS.
- Screening for major congenital heart defects in twin pregnancies between 11+0 and 13+6 weeks gestation
- Second Primary Lung Cancer Associated with Breast Conservation Therapy
- Secondary Malignancies in Patients with Bronchial, Pancreatic, Small Intestinal, and Rectal Neuroendocrine Tumors
- Segesterone Acetate/Ethinyl Estradiol Contraceptive Vaginal System (SA/EE; CVS): An Option That May Be Suitable For Perimenopausal Women
- Self-Reported Efficacy of Hormone Therapy and Symptom Burden in Menopausal Patients with Obesity
- SENESCENCE DURING IN VITRO EMBRYO DEVELOPMENT IN A MURINE MODEL
- Senescence in mammalian embryos as a novel assay for quality control in the IVF laboratory
- Septin 9 is an actin binding protein which bundles F-actin through a unique N-terminal domain.
- Septins enhance the mesenchymal-like motility of renal epithelia by promoting stress fiber connectivity and focal adhesion maturation.
- SERUM ETHINYL ESTRADIOL LEVELS WITH A LOW-DOSE COMBINATION TRANSDERMAL CONTRACEPTIVE (AG200-15) COMPARED WITH A LOW-DOSE COMBINATION ORAL CONTRACEPTIVE
- Serum Lysosomal Acid Lipase Activity as a Potential Non-Invasive Diagnostic Marker for Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
- SEVERE MULTIFACTORIAL PAH: A THERAPEUTIC DILEMMA
- SEVERE MULTIFACTORIAL PAH: A THERAPEUTIC DILEMMA
- Sexual dimorphism in the physiological response of the Apoe(-/-) atherosclerosis model to sleep fragmentation